Brief: IGM Biosciences Q3 Net Income USD -61.989 Million
13/11/2023 21:10
Nov 13 (Reuters) - IGM Biosciences Q3 pretax profit USD -61.749 million. * Q3 basic EPS USD -1.04 * Q3 collaboration revenue USD 509 thousand * Q3 operating income USD -66.76 million * Q3 operating expenses USD 67.269 million
Recent news on IGM Biosciences
See all newsU.S. STOCKS ON THE MOVE-Energy stocks, Apple, Vertex
U.S. STOCKS ON THE MOVE-Snap, Solventum, GlobalFoundries
IGM Biosciences rises on buyout deal with Concentra Biosciences
Brief: Igm Biosciences Enters Into Agreement To Be Acquired By Concentra Biosciences For $1.247 In Cash Per Share Plus A Contingent Value Right
IGM Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary